Dose regimens
Control group: oseltamivir phosphate capsules (Yichang HEC Changjiang Pharmaceutical Co., Ltd), 75 mg once, were administered twice a day for five consecutive days; experimental group: arbidol hydrochloride tablets (CSPC Ouyi Pharmaceutical Co., Ltd), 200 mg, were administered three times a day, for five consecutive days.